Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and...
Vous n'êtes pas connecté
A small study led by researchers at Johns Hopkins Medicine, published on July 25th in Nature Cardiovascular Research, has uncovered how obesity affects muscle structure in patients with a specific type of heart failure known as heart failure with preserved ejection fraction (HFpEF). HFpEF makes up more than half of all heart failure cases globally. […]
Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and...
Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and...
PLAINSBORO, N.J., Aug. 30, 2024 /PRNewswire/ -- Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure...
PLAINSBORO, N.J., Aug. 30, 2024 /PRNewswire/ -- Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure...
PLAINSBORO, N.J., Sept. 3, 2024. The Lancet has published a new pooled, participant-level analysis of patients with heart failure with mildly reduced...
WEDNESDAY, Aug. 28, 2024 -- Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points...
MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.
Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to...
Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to...
Mammals, from the mighty blue whale to the tiny shrew, inhabit nearly every corner of our planet. Their remarkable adaptability to different...